Conversely, transcript levels of ATP-citrate lyase (Acly) and fatty acid synthetase (Fasn) were similar between WT and MPC LivKO (Figure S2G), indicating that changes in fibro-inflammatory state may not impinge on the lipogenic drive component of NASH progression. The gene discussed is FASN; the disease is metabolic dysfunction-associated steatohepatitis.